Metagenomic Sequencing Market Size & Share, By Workflow (Sequencing, Data Processing And Analysis), Product And Services (Reagents And Consumables, Instruments), Technology (16S rRNA Sequencing, Metatranscriptomics), Application (Drug Discovery, Clinical Diagnostics) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 2433| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Metagenomic Sequencing Market size is projected to rise from USD 3.05 billion in 2024 to USD 17.08 billion by 2034, representing a CAGR above 18.8% for the 2025–2034 forecast period. The industry is estimated to reach USD 3.57 billion in revenue by 2025.

Base Year Value (2024)
USD 3.05 billion
CAGR (2025-2034)
18.8%
Forecast Year Value (2034)
USD 17.08 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Metagenomic Sequencing Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: 1. Technological Advancements: Continuous advancements in metagenomic sequencing technologies, such as next-generation sequencing, are driving the growth of the market by enabling faster and more accurate sequencing. 2. Increasing Research and Development Activities: The rising investment in research and development activities in the field of genomics, microbiome, and personalized medicine is fueling the demand for metagenomic sequencing. 3. Growing Application in Healthcare: Metagenomic sequencing is increasingly being used in clinical diagnostics, infectious disease surveillance, and personalized medicine, driving the market growth. 4. Rising Awareness and Adoption: Increasing awareness about the potential benefits of metagenomic sequencing in understanding complex microbial communities and its applications in various industries is propelling market growth. Industry Restraints: 1. High Cost of Sequencing: The high cost associated with metagenomic sequencing instruments and analysis software is a major restraint for market growth, particularly for small research laboratories and healthcare facilities. 2. Data Management and Analysis Challenges: Handling and interpreting the vast amount of data generated from metagenomic sequencing poses a significant challenge, hindering the widespread adoption of the technology. 3. Ethical and Regulatory Concerns: Ethical considerations related to the use of metagenomic sequencing, as well as regulatory hurdles in different regions, can impede market growth by impacting the pace of innovation and adoption.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Metagenomic Sequencing Market
Largest Region
North America
XX% CAGR through 2034
North America (U.S., Canada): The Metagenomic Sequencing Market in North America is expected to witness significant growth, driven by factors such as increasing investment in research and development activities, technological advancements in sequencing technologies, and rising awareness about personalized medicine. The United States holds the largest market share in the region, with a strong presence of key market players and a high level of investment in genomics research. Similarly, Canada is also expected to contribute to the growth of the market, owing to the increasing focus on precision medicine and government initiatives supporting genomics research and development. Asia Pacific (China, Japan, South Korea): The Asia Pacific region is anticipated to exhibit substantial growth in the Metagenomic Sequencing Market. China, as a major hub for pharmaceutical and biotechnology industries, is expected to witness considerable growth in the market. The country's large population base and increasing healthcare expenditure are driving the demand for advanced sequencing technologies for disease diagnosis and treatment. Japan is also a significant market for metagenomic sequencing, owing to the presence of leading market players and a strong emphasis on precision medicine and personalized healthcare. Additionally, South Korea is expected to witness robust growth in the market, driven by increasing government funding for genomics research and the presence of advanced healthcare infrastructure. Europe (United Kingdom, Germany, France): The Metagenomic Sequencing Market in Europe is projected to demonstrate strong growth, supported by factors such as increasing adoption of advanced genomic technologies, high healthcare expenditure, and the presence of several prominent market players. The United Kingdom, in particular, is expected to witness significant market growth, propelled by government initiatives promoting genomics research and precision medicine. Germany, as a leading healthcare market in Europe, is also anticipated to contribute significantly to the growth of the market, driven by increasing investment in healthcare infrastructure and research and development activities. Similarly, France is expected to witness substantial growth in the market, owing to the rising prevalence of chronic diseases and increasing awareness about the potential benefits of metagenomic sequencing in disease diagnosis and treatment.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Segment Analysis of Metagenomic Sequencing Market Workflow: The workflow segment of the metagenomic sequencing market refers to the entire process involved in analyzing microbial communities within environmental samples. This includes steps such as sample collection, DNA extraction, library preparation, sequencing, and bioinformatics analysis. The workflow segment is crucial as it encompasses the entire pipeline of metagenomic sequencing and plays a significant role in determining the quality and accuracy of the results. Product and Services: The product and services segment of the metagenomic sequencing market includes various tools, kits, and platforms used in the process of metagenomic sequencing. This segment comprises DNA extraction kits, library preparation kits, sequencing platforms, and bioinformatics software. Additionally, it also includes the services provided by companies for metagenomic sequencing, such as sample processing, sequencing, and data analysis. The product and services segment is diverse and continues to witness advancements and innovations, contributing to the overall growth of the metagenomic sequencing market. Technology: The technology segment of the metagenomic sequencing market encompasses the various technological platforms and methodologies used for analyzing microbial communities. This includes next-generation sequencing (NGS) technologies, such as Illumina, Pacific Biosciences, and Oxford Nanopore, as well as single-cell sequencing and shotgun metagenomics. The technology segment plays a pivotal role in driving the advancements in metagenomic sequencing, enabling researchers to gain a deeper understanding of microbial diversity and function within a given environment. Application: The application segment of the metagenomic sequencing market refers to the diverse range of fields where metagenomic sequencing is being utilized. This includes fields such as environmental microbiology, clinical diagnostics, agriculture, and industrial biotechnology. Metagenomic sequencing is being increasingly adopted in these areas for its ability to provide insights into microbial communities and their interactions, leading to various applications such as disease diagnosis, bioremediation, and discovery of new microbial enzymes and pathways. The application segment highlights the broad potential of metagenomic sequencing across various industries and research disciplines. In conclusion, the segment analysis of the metagenomic sequencing market showcases the diverse elements that contribute to the growth and development of this field. From the workflow and products/services to the technology and applications, each segment plays a crucial role in advancing metagenomic sequencing and its impact on understanding microbial ecosystems.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The market for metagenomic sequencing is highly competitive, with several key players vying for market share. These companies are continuously investing in research and development to innovate and improve their sequencing technologies, as well as expanding their presence in emerging markets. The competitive landscape is also characterized by strategic partnerships, collaborations, and acquisitions to strengthen their product portfolios and gain a competitive edge. Additionally, the increasing demand for metagenomic sequencing in various applications such as clinical diagnostics, environmental monitoring, and agriculture is further intensifying the competition in the market. Top Market Players: 1. Illumina, Inc. 2. Thermo Fisher Scientific Inc. 3. Qiagen N.V. 4. Oxford Nanopore Technologies, Ltd. 5. Pacific Biosciences of California, Inc. 6. BGI Group 7. F. Hoffmann-La Roche AG 8. PerkinElmer, Inc. 9. Agilent Technologies, Inc. 10. Dovetail Genomics, LLC.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Metagenomic Sequencing Market — Custom Segments

Segment Sub-Segment
No segment data available.

Metagenomic Sequencing Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →